Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic rats

Journal of Nutritional Science and Vitaminology

Volumn 52, Issue 1, 2006, Pages 1-8

  Iwamoto, Jun ^a   Seki, Azusa ^b   Takeda, Tsuyoshi ^a   Sato, Yoshihiro ^c   Yamada, Harumoto ^d   Yeh, James K ^e  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hamri Co Ltd   (Japan)

^c Mitate Hospital   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

^e WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Alendronate; Alfacalcidol; Osteopenia; Ovariectomy; Therapy

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; DEOXYPYRIDINOLINE; DRUG VEHICLE; OSTEOCALCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCELLOUS BONE; CONTROLLED STUDY; CORTICAL BONE; DIAPHYSIS; DOSE RESPONSE; DRUG INHIBITION; DRUG MECHANISM; FEMALE; METAPHYSIS; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOPENIA; POSTMENOPAUSE OSTEOPOROSIS; RAT; TIBIA;

ALENDRONATE; AMINO ACIDS; ANIMALS; BIOMECHANICS; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIUM; FEMALE; HYDROXYCHOLECALCIFEROLS; OSTEOCALCIN; OVARIECTOMY; PHOSPHORUS; RATS; RATS, SPRAGUE-DAWLEY; TIBIA;

ANIMALIA;

EID: 33645764664     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.52.1     Document Type: Article

References (15)

1. Shiraki M, Kushida K, Fukunaga M, Kishimoto H, Taga M, Nakamura T, Kaneda K, Minaguchi H, Inoue T, Morii H, Tomita A, Yamamoto K, Nagata Y, Nakashima M, Orimo H. The Alendronate Phase III Osteoporosis Treatment Research Group. 1999. A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. Osteoporos Int 10: 183-192.
2. Kushida K, Shiraki M, Nakamura T, Kishimoto H, Morii H, Yamamoto K, Kaneda K, Fukunaga M, Inoue T, Nakashima M, Orimo H. 2004. Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis: a 3-year follow-up study. J Bone Miner Metab 22: 462-468.
3. Toolan BC, Shea M, Myers ER, Borchers RE, Seedor JG, Quartuccio H, Rodan G, Hayes WC. 1992. Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats. J Bone Miner Res 7: 1399-1406.
4. 3 on bone loss by ovariectomy in aged rats. Jpn J Pharmacol 89: 255-266.
5. 3 and estrogen therapy on cortical bone mechanical properties in the ovariectomized rat model. Endocrinology 137: 1358-1364.
6. Azuma Y, Oue Y, Kanatani H, Ohta T, Kiyoki M, Komoriya K. 1998. Effects of continuous alendronate treatment on bone mass and mechanical properties in ovariectomized rats: comparison with pamidronate and etidronate in growing rats. J Pharmacol Exp Ther 286: 128-135.
7. Shiraishi A, Takeda S, Masaki T, Higuchi Y, Uchiyama Y, Kubodera N, Sato K, Ikeda K, Nakamura T, Matsumoto T, Ogata E. 2000. Alfacalcidol inhibits bone resorption and stimulate formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen. J Bone Miner Res 15: 770-779.
8. Shiraishi A, Higashi S, Masaki T, Saito M, Ito M, Ikeda S, Nakamura T. 2002. A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis. Calcif Tissue Int 71: 69-79.
9. Ito M, Nishida A, Koga A, Ikeda S, Shiraishi A, Uetani M, Hayashi K, Nakamura T. 2002. Contribution of trabecular and cortical components to the mechanical properties of bone and their regulating parameters. Bone 31: 351-358.
10. Erben RG. 1997. Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry. J Histochem Cytochem 45: 307-313.
11. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASMBR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595-610.
12. Seeman E. 2003. Periosteal bone formation-a neglected determinant of bone strength. N Engl J Med 349: 320-323.
13. 2 combine to improve the femoral neck strength of ovariectomized rats. Calcif Tissue Int 77: 119-126.
14. Sato M, Bryant HU, Iversen P, Helterbrand J, Smietana F, Bemis K, Higgs R, Turner CH, Owan I, Takano Y, Burr DB. 1996. Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats. J Pharmacol Exp Ther 279: 298-305.
15. Epstein S. 2005. The roles of bone mineral density, bone turnover, and other properties in reducing fracture risk during antiresorptive therapy. Mayo Clin Prof 80: 379-388.